4 Results for "

PPARγ LBD

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PPARγ LBD" in MCE Product Catalog:

Cat. No.: HY-117727A
CAS No.: 146062-46-6
Purity:  99.64%
Synonyms: MIN-102 hydrochloride; Hydroxypioglitazone hydrochloride
Leriglitazone (MIN-102; Hydroxypioglitazone) hydrochloride is an orally active and a BBB-penetrable PPARγ agonist with an EC50 of 9 μM. Leriglitazone hydrochloride, as a regulator of mitochondrial function, has neuroprotective, anti-inflammatory and antioxidant effects. Leriglitazone hydrochloride can be used in the study of neuroinflammatory and neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-113827
CAS No.: 100079-26-3
Purity:  98.00%
THPN is a potent Nur77 agonist. THPN specifically binds the LBD of Nur77 (TR3) but not that of retinoic acid receptor α and PPARγ with a Kd of 270 nM. THPN leads to Nur77 translocation to the mitochondria to induce autophagic cell death in melanoma .
loading...
    loading...
Cat. No.: HY-168719
CAS No.: 2218046-01-4
Target:  

PPAR

Research Areas:  

Inflammation/Immunology

PPARγ agonist 16 (Compound 4G) is the agonist for PPARγ, that competitively binds to LBD domain of PPARγ with IC50 of 1790 nM. PPARγ agonist 16 inhibits the ear swelling in mouse model, and exhibits anti-hyperglycemic in Streptozotocin (HY-13753)-induced mouse diabetes mellitus model .
loading...
    loading...
Cat. No.: HY-170874
CAS No.: 2897652-01-4
Target:  

PPAR

Research Areas:  

Metabolic Disease

PPARγ modulator-2 (Compound (R)-2n) is the reversible modulator for PPARγ that inhibits PPARγ ligand-binding domain (LBD) with an IC50 of 41 nM. PPARγ modulator-2 reduces blood glucose, improves the glucose tolerance and insulin tolerance, and exhibits anti-diabetic efficacy in db/db mouse models .
loading...
    loading...